Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Cash from Financing Activities: 2018-2024

Historic Cash from Financing Activities for Fulcrum Therapeutics (FULC) over the last 7 years, with Dec 2024 value amounting to $2.7 million.

  • Fulcrum Therapeutics' Cash from Financing Activities fell 89.92% to $64,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 63.29%. This contributed to the annual value of $2.7 million for FY2024, which is 97.68% down from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Cash from Financing Activities of $2.7 million as of FY2024, which was down 97.68% from $118.1 million recorded in FY2023.
  • In the past 5 years, Fulcrum Therapeutics' Cash from Financing Activities registered a high of $186.5 million during FY2021, and its lowest value of $2.7 million during FY2024.
  • For the 3-year period, Fulcrum Therapeutics' Cash from Financing Activities averaged around $68.4 million, with its median value being $84.3 million (2022).
  • As far as peak fluctuations go, Fulcrum Therapeutics' Cash from Financing Activities soared by 162.20% in 2021, and later tumbled by 97.68% in 2024.
  • Yearly analysis of 5 years shows Fulcrum Therapeutics' Cash from Financing Activities stood at $71.1 million in 2020, then skyrocketed by 162.20% to $186.5 million in 2021, then tumbled by 54.79% to $84.3 million in 2022, then spiked by 40.08% to $118.1 million in 2023, then plummeted by 97.68% to $2.7 million in 2024.